Elanco Animal Health
(NYSE) ELAN
Elanco Animal Health Financials at a Glance
Market Cap
$10.85B
Revenue (TTM)
$4.89B
Net Income (TTM)
$242.00M
EPS (TTM)
$-0.49
P/E Ratio
-44.41
Dividend
$0.00
Beta (Volatility)
1.23 (Average)
Dividend
$0.00
Beta (Volatility)
1.23 (Average)
Price
$21.45
Volume
430,904
Open
$21.72
Price
$21.45
Volume
430,904
Open
$21.72
Previous Close
$21.45
Daily Range
$21.18 - $22.02
52-Week Range
$12.40 - $27.72
Dividend
$0.00
Beta (Volatility)
1.23 (Average)
Price
$21.45
Volume
430,904
Open
$21.72
Previous Close
$21.45
Daily Range
$21.18 - $22.02
52-Week Range
$12.40 - $27.72
ELAN News
ELAN: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Elanco Animal Health
Industry
Pharmaceuticals
Sector
Health CareEmployees
9,900
CEO
Jeffrey N. Simmons
Website
www.elanco.comHeadquarters
Greenfield, IN 46140, US
ELAN Financials
Key Financial Metrics (TTM)
Gross Margin
49%
Operating Margin
9%
Net Income Margin
-5%
Return on Equity
-4%
Return on Capital
4%
Return on Assets
-2%
Earnings Yield
-2.25%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$10.85B
Shares Outstanding
499.45M
Volume
430.90K
Avg. Volume
5.36M
Financials (TTM)
Gross Profit
$2.05B
Operating Income
$252.00M
EBITDA
$676.00M
Operating Cash Flow
$560.00M
Capital Expenditure
$276.00M
Free Cash Flow
$284.00M
Cash & ST Invst.
$545.00M
Total Debt
$4.02B
Elanco Animal Health Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$1.37B
+14.9%
Gross Profit
$785.00M
+41.2%
Gross Margin
57.26%
N/A
Market Cap
$10.85B
N/A
Market Cap/Employee
$1.21M
N/A
Employees
9,000
N/A
Net Income
$57.00M
-14.9%
EBITDA
$307.00M
+12.0%
Quarterly Fundamentals
Net Cash
$3.56B
+8.8%
Accounts Receivable
$1.15B
+8.9%
Inventory
$1.72B
+7.9%
Long Term Debt
$3.92B
-10.0%
Short Term Debt
$73.00M
+65.9%
Return on Assets
-1.83%
N/A
Return on Invested Capital
3.79%
N/A
Free Cash Flow
$38.00M
+44.9%
Operating Cash Flow
$13.00M
+425.0%